Results 31 to 40 of about 1,561,331 (181)

Antipsychotic Agents: A Clinical Update [PDF]

open access: yesMayo Clinic Proceedings, 1985
Antipsychotic agents have many indications and are frequently used. All physicians, regardless of their subspecialty, will most likely treat patients who receive these drugs. This article is designed to help nonpsychiatric physicians use antipsychotics appropriately.
J L, Black   +2 more
openaire   +2 more sources

Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence? [PDF]

open access: yes, 2012
Background: Little is known about the factors influencing treatment choice in psychosis, the majority of this work being conducted with specialists (consultant) in psychiatry.
Nwachukwu Izu   +73 more
core   +4 more sources

Neuropsychological assessment and treatment possibilities of cognitive deficit in schizophrenic patients [PDF]

open access: yesVojnosanitetski Pregled, 2012
nema
Totić-Poznanović Sanja   +4 more
doaj   +1 more source

The therapeutic relationship and adherence to antipsychotic medication in schizophrenia [PDF]

open access: yes, 2012
OBJECTIVE: Previous research has shown that a better therapeutic relationship (TR) predicts more positive attitudes towards antipsychotic medication, but did not address whether it is also linked with actual adherence.
McCabe, R   +68 more
core   +2 more sources

CLOZAPINE AND HALOPERIDOL INCREASE THE EXPRESSION OF PED/PEA-15: A PUTATIVE NOVEL MECHANISM FOR ANTIPSYCHOTIC-RELATED DIABETES [PDF]

open access: yes, 2008
Schizophrenia is a serious disorder that affects 1% of the population in the United States and Europe, and is associated with a significant reduction in life expectancy that approaches 20% compared with that of the general population.
Panariello, Fabio
core   +1 more source

Direct and Indirect Drug Design Approaches for the Development of Novel Tricyclic Antipsychotics: Potential 5-HT2A Antagonist

open access: yesJournal of Chemistry, 2013
Schizophrenia is a mental disorder manifested largely by disintegration of thought processes and emotional responsiveness. Given the therapeutic and toxic limitations of clinically available drugs, it is clear that there is still a need for the ...
Mahantesh Namdev Jadhav   +3 more
doaj   +1 more source

QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy

open access: yesAnnals of General Psychiatry, 2005
Background Several antipsychotic agents are known to prolong the QT interval in a dose dependent manner. Corrected QT interval (QTc) exceeding a threshold value of 450 ms may be associated with an increased risk of life threatening arrhythmias ...
Piccinelli Marco   +9 more
doaj   +1 more source

Assessment of adherence to treatment with injectable extended-release antipsychotics within a pharmacotherapeutic follow-up program [PDF]

open access: yesFarmacia Hospitalaria, 2019
Objective: To describe an injectable extended-release antipsychotic pharmacotherapeutic follow-up program and to assess adherence among patients included in the program.
Carmen Gallastegui   +5 more
doaj   +1 more source

Neuroleptic malignant syndrome

open access: yesJournal of Family Medicine and Primary Care, 2016
Neuroleptic malignant syndrome (NMS) is a life-threatening emergency that is often seen as a complication of antipsychotic agents. It is characterized by a tetrad of motor, behavioral, autonomic, and laboratory abnormalities.
Bino Rajamani   +2 more
doaj   +1 more source

Existing and emerging pharmacological approaches to the treatment of mania: A critical overview

open access: yesTranslational Psychiatry, 2022
Manic episodes are a defining, frequent and dramatically disabling occurrence in the course of Bipolar Disorder type I. Current pharmacotherapy of mania lists a good number of agents, but differences in efficacy and safety profiles among these agents ...
Giulio Sparacino   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy